735
Participants
Start Date
October 1, 2025
Primary Completion Date
October 1, 2027
Study Completion Date
October 1, 2032
ENDORISK personalized risk assesment for lymph node metastases in endometrial cancer.
The intervention group are patients receiving a personalized risk on lymph node metastases as predicted by the ENDORISK model, they also receive a treatment plan (hysterectomy + bilateral salpingo-oophorectomy with or without lymph node surgery) based on this personalized risk.
Rijnstate, Arnhem
Slingeland Hospital, Doetinchem
Gelderse Vallei, Ede
Canisius Wilhelmina Ziekenhuis (CWZ), Nijmegen
Streekziekenhuis Koningin Beatrix, Winterswijk
Jeroen Bosch Hospital, 's-Hertogenbosch
Amphia, Breda
Catharina Hospital, Eindhoven
St. Anna Hospital, Geldrop
Elkerliek Hospital, Helmond
Elisabeth-Tweesteden Hospital, Tilburg
Bernhoven Hospital, Uden
Maxima Medical Center, Veldhoven
Radboudumc, Nijmegen
Collaborators (1)
Elisabeth-TweeSteden Ziekenhuis
OTHER
Amphia Hospital
OTHER
Catharina Ziekenhuis Eindhoven
OTHER
Elkerliek Hospital
OTHER
St. Anna Ziekenhuis, Geldrop, Netherlands
OTHER
Jeroen Bosch Ziekenhuis, s'-Hertogenbosch
UNKNOWN
Rijnstate Hospital
OTHER
Canisius Wilhelmina Ziekenhuis (CWZ)
UNKNOWN
Maxima Medical Center
OTHER
Bernhoven Hospital
OTHER
Maas Hospital Pantein
OTHER
Slingeland Hospital
OTHER
Streekziekenhuis Koningin Beatrix
UNKNOWN
Gelderse Vallei Hospital
OTHER
Comprehensive Cancer Centre The Netherlands
OTHER
Stichting PAMM
UNKNOWN
Radboud University Medical Center
OTHER